DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Mobile Imaging
SEARCH
Ubicación actual:
>
> This Story


Conexión o Registro to rate this News Story
Forward Printable StoryPrint Comment

 

Molecular Imaging Homepage

Global PET/CT scanner market projected to reach $2.1 billion by 2023 Growth spurred in part by increased Medicare coverage

Can theranostics be the key to completely curing colorectal cancer? Preclinical trials yield promising results

Cerveau Technologies to collaborate in development of PET imaging agents for Alzheimer’s disease

MJFF and Tau Consortium partner to accelerate the development of new PET tracers May detect early stage neurodegenerative disease

Cerveau inks deal with AbbVie for investigational tau imaging PET agent Stage III clinical trial to begin in next few months

New molecular imaging technology for prostate cancer may improve surgical outcomes Lightpoint Medical forges new partnerships

New imaging system may accelerate drug development for Alzheimer's cryo-MOST provides more detail than MR and PET

Phase I trial demonstrates safe use of radiotracer produced in minutes Manufactured using a Ga-68 generator and a cold kit vial

Bracco Imaging acquires SurgVision Enables development of a real-time fluorescence image-guided surgery platform

Blue Earth Diagnostics inks Axumin deal with Seibersdorf Laboratories Manufacturing and distribution in certain European countries

GE Healthcare's Omniscan
Gadolinium-based contrast media

Courtesy of Wikimedia

Researchers develop method that generates multi-color MR images

por Lauren Dubinsky , Senior Reporter
Researchers at Case Western Reserve University School of Medicine found out how to make MR images multicolor.

They did that by developing a new method that uses two contrast agents at once. This allows physicians to map multiple characteristics of a patient's internal organs from a single MR exam.

Story Continues Below Advertisement

The (#1 Resource) for Medical Imaging and Peripherals. Call 1-949-273-8000

As a Master Distributor for major brands Barco, Philips, and Sony, we offer custom imaging solutions. With our renowned OEM Solutions and Service/Repair Center, Ampronix is a one-stop shop for HD Medical LCD Displays--Printers--Recorders--4K Cameras



"The multicolored term is used here to [explain] that this new MRI technique is analogous to simultaneous detection of two optical imaging agents that use different fluorophores (e.g., red and green)," Chris Flask, associate professor at the university, told HCB News.

He believes that this multi-agent detection capability has the potential to transform molecular imaging because it provides a translation pathway for studies in patients. It also provides a unique imaging platform to rigorously study molecular therapies that target biomarkers or other detectable molecules associated with certain diseases.

In addition to a research tool, this method could also be used to diagnose. One of the contrast agents could specifically target the diseased tissue and the other could be designed to show healthy tissue.

Flask and his team recently published a paper that discussed their new method in Scientific Reports. They used gadolinium and manganese, which can be detected and independently quantified during MR exams.

The team stated that their results provide "an adaptable, quantitative imaging framework to assess two MR contrast agents simultaneously for a wide variety of imaging applications."

They have already started to investigate potential applications for the new method. Those may include studies in cancers, genetic diseases like cystic fibrosis, and metabolic diseases such as diabetes.

Flask noted that both combinations of two FDA-approved agents, as well as new molecular MR contrast agents, will need to be evaluated for safety and benefits to patient populations.

"However, this new MR technology opens the door to considering those combinations of agents that will be first evaluated in basic science studies, and then eventually in patients," he added.

Molecular Imaging Homepage


You Must Be Logged In To Post A Comment

Anuncie
Aumente su conciencia de marca
Subastas + ventas Privadas
Consigue el mejor precio
Comprar Equipo/Piezas
Encuentra El Precio Más Bajo
Noticias diarias
Lee las últimas noticias
Directorio
Examina todos los usuarios DOTmed
Ética en DOTmed
Ver nuestro programa de ética
El oro parte programa del vendedor
Recibir las solicitudes de PH
Programa de distribuidor con servicio gold
Recibe solicitudes
Proveedores de atención de salud
Ver todos los HCP (abreviatura de asistencia médica) Herramientas
Trabajos/Entrenamiento
Encontrar/rellenar un trabajo
Parts Hunter +EasyPay
Obtener presupuestos para piezas
Certificado recientemente
Ver usuarios certificados recientemente
Recientemente clasificado
Ver usuarios certificados recientemente
Central de alquiler
Alquila equipos por menos
Vende equipos/piezas
Obtén más dinero
Mantenga el foro de los técnicos
Buscar ayuda y asesoramiento
Petición sencilla de propuestas
Obtén presupuestos para equipos
Feria comercial virtual
Encuentra servicio para el equipo
El acceso y el uso de este sitio está conforme a los términos y a las condiciones de nuestro AVISO LEGAL & AVISO DE LA AISLAMIENTO
Característica de y propietario DOTmeda .com, inc. Copyright ©2001-2017 DOTmed.com, Inc.
TODOS LOS DERECHOS RESERVADOS